Diazepam diminishes temozolomide efficacy in the treatment of U87 glioblastoma cell line

AIMS: Many patients with glioblastoma (GBM) suffer from comorbid neurological/psychiatric disorders and, therefore, are treated with psychopharmacological agents. Diazepam (DIA) is widely adopted to treat status epilepticus, alleviate anxiety, and inhibit chemotherapy‐associated delayed emesis in GB...

Descripción completa

Detalles Bibliográficos
Autores principales: Drljača, Jovana, Popović, Aleksandra, Bulajić, Dragica, Stilinović, Nebojša, Vidičević Novaković, Sašenka, Sekulić, Slobodan, Milenković, Ivan, Ninković, Srđan, Ljubković, Marko, Čapo, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344091/
https://www.ncbi.nlm.nih.gov/pubmed/35703405
http://dx.doi.org/10.1111/cns.13889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344091/
https://www.ncbi.nlm.nih.gov/pubmed/35703405
http://dx.doi.org/10.1111/cns.13889

Ejemplares similares